SCHEMBL22952973

SCHEMBL22952973

Cc1nc(O)c2c3c1Oc1c(ccc(O)c1O)C3CNC2

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.38
KIF11 P52732 1/20 0.34
MAPK1 P28482 2/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
THPO P40225 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
PMP22 Q01453 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22953343 0.81 PARP1 (0.41) PARP1KIF11MAPK1CYP3A4ALOX15
SCHEMBL22952976 0.79 HTR2A (0.33) PARP1MAPK1CYP3A4ALOX15TSHR
SCHEMBL22953386 0.79 PARP1 (0.39) PARP1KIF11LMNA
SCHEMBL22953344 0.76 PARP1 (0.39) PARP1MAPK1CYP3A4ALOX15TSHR
SCHEMBL22953341 0.73 PARP1 (0.43) PARP1MAPK1CYP3A4ALOX15TSHR
SCHEMBL22952977 0.70 DRD1 (0.33) PARP1MAPK1CYP3A4ALOX15TSHR
SCHEMBL6345215 0.69 HTR2A (0.46) PARP1MAPK1CYP3A4ALOX15TSHR
SCHEMBL29383649 0.69 HTR2A (0.46) PARP1MAPK1CYP3A4ALOX15TSHR
SCHEMBL22952971 0.69 HTR2A (0.35) PARP1MAPK1CYP3A4ALOX15TSHR
Bromide SCHEMBL3668719 0.68 HTR2A (0.45) PARP1MAPK1CYP3A4ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021922-A1 COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2021-02-04 WO disclosed